GSK Raises Product Prices in US And Europe As Costs Rise

GSK revealed price increases in the US, Europe and China as it posted Q3 sales up high single-digits, with gains in key categories such as pain relief and vitamins, minerals and supplements.

arrows pointing upwards
• Source: Alamy

GlaxoSmithKline Consumer Healthcare is rolling out product price increases around the globe in a response to further pressure from cost inflation.

More from Earnings

More from Business

Principle Relaunches Vitawell To Help Consumers Navigate UK Supplement ‘Minefield’

 
• By 

Vitawell seeking to empower consumers left confused by the vast array of dietary supplements available to them in the UK.

Swisse Benefits As Supplements Considered ‘Daily Necessity’ In China

 
• By 

Chinese consumers are now routinely taking supplements for a variety of health reasons, helping to drive up sales of the Swisse Plus+ brand by 20% in 2024.

OptiBiotix Benefitting From Popularity Of Anti-Obesity Drugs

 
• By 

Growing use of GLP-1 receptor agonists is having a positive knock-on effect on the dietary supplements market, reports OptiBiotix Health, marketer of the SlimBiome weight management prebiotic.